Actavia Life Sciences, Inc. (RASP)
OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0095 (-95.00%)
At close: Dec 26, 2025
Actavia Life Sciences Market Cap
Actavia Life Sciences has a market cap or net worth of $385.91 thousand as of January 23, 2026. Its market cap has decreased by -99.85% in one year.
Market Cap
385.91K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 14, 2016, Actavia Life Sciences's market cap has decreased from 71.15M to 385.91K, a decrease of -99.46%. That is a compound annual growth rate of -43.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 385.91K | -83.28% |
| Dec 14, 2021 | 2.31M | -33.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 628.70K |
| Scorpius Holdings | 611.43K |
| Innovation Pharmaceuticals | 528.77K |
| Regenerative Medical Technology Group | 515.05K |
| Bio-Path Holdings | 502.77K |
| Helix BioMedix | 449.42K |
| CNBX Pharmaceuticals | 348.31K |
| Oncology Pharma | 334.65K |